|
|
An Efficient Monoclonal Establishment Method of Genetically Modified Human Pluripotent Stem Cells |
QIAN Yu1,DING Xiao-yu2,LIU Zhi-qiang2,*(),YUAN Zeng-qiang2,*() |
1 College of Graduate Studies, University of South China, Hengyang 421001, China 2 Institute of Military Cognition and Brain Sciences, Beijing 100850, China |
|
|
Abstract Objective: To provide a method that can significantly improve the stable transfection of lentivirus into human pluripotent stem cells, and establish a simple and a non-invasive screening method for transfected cells. Methods: In the process of lentivirus transfection of human pluripotent stem cells, we compared the dynamic changes of cell morphology with and without Y-27632, and the differences of lentivirus particles uptake ability under different cell morphologies, so as to optimize and establish an efficient lentivirus transfection method. After that, a visualized and simple micromanipulation device was designed and developed to explore the technology of picking up the transfected positive monoclone cells to establish a line with the aid of a fluorescence microscope, and establish a relatively simple new method for purification of transfected cells. Results: The morphology of normal cultured human pluripotent stem cells colony changed significantly 6 hours after Y-27632 was added. The cells were in loose colony showing a long spindle shape, and an increased cell surface area; The colonies returned to normal 6 hours after removal; In conventionally cultured pluripotent stem cells, lentivirus tended to enter the colony periphery or partial cells; after Y-27632 was treated for 6 hours in advance, the pluripotent stem cells showed a loose colony and a significant increased surface, making the lentivirus infect more evenly into the periphery and internal of the colony. It significantly improved the efficiency of lentiviral transfection. Using the capillary glass tube, we designed and manufactured independently a single colony selection device that was visualized under a microscope. With the aid of a microscope, the selection and establishment of successfully transfected colony can be easily performed in the laboratory. It can replace puromycin screening with certain cell damage and the flow cytometry which requires professional equipment. Conclusions: In the process of lentiviral transfection, the hESC / IPSC colonies cultured in conventional condition were relatively dense and resistant to lentivirus. Y-27632, a small molecule compound, made the hESC / IPSC colonies relatively loose in structure and increased the surface area, which significantly improved the susceptibility of cells to lentivirus and improved the infection efficiency; a simple and non-toxic micromanipulation device was successfully designed under conventional laboratory conditions, and it can effectively replace flow cytometry and drug screening, and realize the selection of cell clones and finally the establishment of cell lines.
|
Received: 07 March 2021
Published: 31 August 2021
|
|
Corresponding Authors:
Zhi-qiang LIU,Zeng-qiang YUAN
E-mail: biodiagnosis_liu@163.com;zqyuan@bmi.ac.cn
|
|
|
[1] |
Shahror R A, Wu C C, Chiang Y H, et al. Genetically modified mesenchymal stem cells: the next generation of stem cell-based therapy for TBI. International Journal of Molecular Sciences, 2020, 21(11):4051.
doi: 10.3390/ijms21114051
|
|
|
[2] |
Nedelec S, Onteniente B, Peschanski M, et al. Genetically-modified human pluripotent stem cells: new hopes for the understanding and the treatment of neurological diseases? Current Gene Therapy, 2013, 13(2):111-119.
doi: 10.2174/1566523211313020005
|
|
|
[3] |
Nowakowski A, Andrzejewska A, Janowski M, et al. Genetic engineering of stem cells for enhanced therapy. Acta Neurobiologiae Experimentalis, 2013, 73(1):1-18.
pmid: 23595280
|
|
|
[4] |
Liew A, André F M, Lesueur L L, et al. Robust, efficient, and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses. Human Gene Therapy Methods, 2013, 24(5):289-297.
doi: 10.1089/hgtb.2012.159
|
|
|
[5] |
Picanco-Castro V, de Sousa Russo-Carbolante E M, Tadeu Covas D. Advances in lentiviral vectors: a patent review. Recent Patents on DNA & Gene Sequences, 2012, 6(2):82-90.
|
|
|
[6] |
Dwivedi P P, Anderson P J, Powell B C. Development of an efficient, non-viral transfection method for studying gene function and bone growth in human primary cranial suture mesenchymal cells reveals that the cells respond to BMP2 and BMP3. BMC Biotechnology, 2012, 12:45.
doi: 10.1186/1472-6750-12-45
pmid: 22857382
|
|
|
[7] |
Bokhoven M, Stephen S L, Knight S, et al. Insertional gene activation by lentiviral and gammaretroviral vectors. Journal of Virology, 2009, 83(1):283-294.
doi: 10.1128/JVI.01865-08
pmid: 18945765
|
|
|
[8] |
Kobayashi N, Rivas-Carrillo J D, Soto-Gutierrez A, et al. Gene delivery to embryonic stem cells. Birth Defects Research Part C,Embryo Today, 2005, 75(1):10-18.
doi: 10.1002/(ISSN)1542-9768
|
|
|
[9] |
Zhang Q Y, Li X D, Liu S Q, et al. Development of a stable Japanese encephalitis virus replicon cell line for antiviral screening. Archives of Virology, 2017, 162(11):3417-3423.
doi: 10.1007/s00705-017-3508-9
|
|
|
[10] |
Givan A L. Flow cytometry: an introduction. Methods in Molecular Biology (Clifton, N J), 2011, 699:1-29.
|
|
|
[11] |
Kim K, Min S, Kim D, et al. A rho kinase (ROCK) inhibitor, Y-27632, inhibits the dissociation-induced cell death of salivary gland stem cells. Molecules, 2021, 26(9):2658.
doi: 10.3390/molecules26092658
|
|
|
[12] |
Rezania A, Bruin J E, Arora P, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature Biotechnology, 2014, 32(11):1121-1133.
doi: 10.1038/nbt.3033
|
|
|
[13] |
Ungrin M D, Joshi C, Nica A, et al. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One, 2008, 3(2):e1565.
|
|
|
[14] |
Kurosawa H. Application of Rho-associated protein kinase (ROCK) inhibitor to human pluripotent stem cells. Journal of Bioscience and Bioengineering, 2012, 114(6):577-581.
doi: 10.1016/j.jbiosc.2012.07.013
pmid: 22898436
|
|
|
[15] |
Narumiya S, Thumkeo D. Rho signaling research: history, current status and future directions. FEBS Letters, 2018, 592(11):1763-1776.
doi: 10.1002/1873-3468.13087
pmid: 29749605
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|